Trevena
TRVN
#10609
Rank
HK$0.08 M
Marketcap
HK$0.09342
Share price
0.00%
Change (1 day)
-99.26%
Change (1 year)

Trevena (TRVN) - Cash on Hand

Cash on Hand as of September 2024 : HK$0.10 Billion

According to Trevena's latest financial reports the company has HK$0.10 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Trevena - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$0.25 B-13.98%
2022-12-31HK$0.29 B-42.62%
2021-12-31HK$0.52 B-38.47%
2020-12-31HK$0.84 B204.14%
2019-12-31HK$0.27 B-42.08%
2018-12-31HK$0.48 B-6.77%
2017-12-31HK$0.51 B-39.79%
2016-12-31HK$0.85 B-35.9%
2015-12-31HK$1.33 B61.37%
2014-12-31HK$0.82 B181.66%
2013-12-31HK$0.29 B463.62%
2012-12-31HK$52.23 M-60.58%
2011-12-31HK$0.13 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
HK$73.52 B 70,060.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
HK$7.49 B 7,050.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
HK$0.29 B 181.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$141.78 B 135,199.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
HK$73.02 M-30.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA